North Eastern German Society of Gynaecological Oncology

🇩🇪Germany
Ownership
Private
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer

Phase 2
Completed
Conditions
Ovarian Cancer
Interventions
Drug: Caelyx
First Posted Date
2005-09-15
Last Posted Date
2024-12-16
Lead Sponsor
North Eastern German Society of Gynaecological Oncology
Target Recruit Count
77
Registration Number
NCT00170573

Topotecan Weekly Versus Topotecan Day 1-5 in Patient With Platin-resistant Ovarian Cancer

Phase 2
Completed
Conditions
Ovarian Cancer
Interventions
Drug: Topotecan
First Posted Date
2005-09-15
Last Posted Date
2014-05-14
Lead Sponsor
North Eastern German Society of Gynaecological Oncology
Target Recruit Count
194
Registration Number
NCT00170677
Locations
🇩🇪

Charité Campus Virchow-Klinikum, Berlin, Germany

Therapy With Topotecan and Carboplatin by Patients With Relapsed Ovarian Cancer

Phase 1
Completed
Conditions
Ovarian Cancer
Interventions
Drug: Hycamtin
First Posted Date
2005-09-15
Last Posted Date
2024-11-11
Lead Sponsor
North Eastern German Society of Gynaecological Oncology
Target Recruit Count
28
Registration Number
NCT00170625

Taxol/ Carboplatin as First Line Therapy in Patients With Epithelial Ovarian Cancer

Phase 2
Completed
Conditions
Ovarian Cancer
Interventions
Drug: Paclitaxel
Drug: Carboplatin
First Posted Date
2005-09-15
Last Posted Date
2016-03-25
Lead Sponsor
North Eastern German Society of Gynaecological Oncology
Target Recruit Count
129
Registration Number
NCT00170664
Locations
🇩🇪

Charité Campus Virchow-Klinikum, Berlin, Germany

Taxol Carboplatin and Erythropoetin

Phase 2
Completed
Conditions
Ovarian Cancer
Interventions
Drug: Paclitaxel
First Posted Date
2005-09-12
Last Posted Date
2017-02-06
Lead Sponsor
North Eastern German Society of Gynaecological Oncology
Target Recruit Count
105
Registration Number
NCT00158379
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy